FTC's Teva Settlement A Sign Of Enforcement Evolution
The Federal Trade Commission's settlement this week with Teva Pharmaceuticals further winnows the types of deals the company can sign with would-be competitors and illuminates the agency's evolving approach to cases...To view the full article, register now.
Already a subscriber? Click here to view full article